It is noteworthy that in a focused analysis of a subset of 1, 018 cases and 774 controls from the GD-SYSUCC cohort, who had serological data for the EBV-encoded virus capsule antigen (EBV VCA-IgA), we observed a stronger association between rcPRS and NPC susceptibility in EBV seropositive individuals (Figure 3E). Here, CD79A is linked to nasopharyngeal carcinoma.